HPV types present in invasive cervical cancers of HIV-seropositive women.
Howard D
HD
Strickler
Joel M
JM
Palefsky
Robert D
RD
Burk
D018791:CD4 Lymphocyte Count; D005260:Female; D018023:HIV Seronegativity / Q000276:immunology; D006679:HIV Seropositivity / Q000150:complications* / Q000276:immunology; D052162:Human papillomavirus 16 / Q000276:immunology* / Q000302:isolation & purification; D006801:Humans; D007391:International Cooperation; D007630:Kenya / Q000453:epidemiology; D054547:National Cancer Institute (U.S.); D009361:Neoplasm Invasiveness; D030361:Papillomavirus Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D016036:Seroepidemiologic Studies; D014412:Tumor Virus Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology* / Q000821:virology*
D053918:Papillomavirus Vaccines